Search Result "CDKN1B."
Hsa_circ_0000437 Inhibits the Development of Endometrial Carcinomathrough miR-626/CDKN1B Axis
Journal: Protein & Peptide Letters
Volume: 29 Issue: 7 Year: 2022 Page: 611-620
Author(s):
A Comparison of the Anti-Cancer Effects of Free and PLGA-PAA EncapsulatedHydroxytyrosol on the HT-29 Colorectal Cancer Cell Line
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 2 Year: 2022 Page: 390-394
Author(s): Nasrin S. Sani,Habib Onsori,Somayeh Akrami,Mohammad Rahmati
Emerging Biomarkers and Contributing Factors of Prostate Cancer.
Journal: Current Cancer Therapy Reviews
Volume: 16 Issue: 0 Year: 2020 Page: 1-19
Author(s): Mini Dahiya,Monu Yadav,Kalpana Nagpal,Nidhi Sharma,Kajal Joshi,Monika Kadian
Effect of Vinca Alkaloids on the Expression Levels of microRNAs Targeting Apoptosis-related Genes in Breast Cancer Cell Lines
Journal: Current Pharmaceutical Biotechnology
Volume: 19 Issue: 13 Year: 2018 Page: 1076-1086
Author(s): Adamantios V. Mavrogiannis,Ioanna Kokkinopoulou,Christos K. Kontos,Diamantis C. Sideris
Antitumoral Activity of Indole-3-carbinol Cyclic tri- and Tetrameric Derivatives Mixture in Human Breast Cancer Cells: In Vitro and In Vivo Studies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 4 Year: 2013 Page: 654-662
Author(s): Giorgio Brandi, Alessandra Fraternale, Simone Lucarini, Mirko Paiardini, Mauro De Santi, Barbara Cervasi, Maria F. Paoletti, Luca Galluzzi, Andrea Duranti, Mauro Magnani
Primary Hyperparathyroidism & Benign Diseases
Ebook: Hypercalcemia Pathophysiology & Treatment
Volume: 1 Year: 2010
Author(s): Franco Lumachi,Stefano M.M. Basso
Doi: 10.2174/978160805107611001010018
Mechanistic Investigation of Glycyrrhiza uralensis Effects against RespiratoryAilments: Application of Network Pharmacology and MolecularDocking Approaches
Journal: Letters in Drug Design & Discovery
Volume: 19 Issue: 5 Year: 2022 Page: 397-412
Author(s): Munazza Ijaz,Manal Buabeid,Tahir Ali Chohan,Ghulam Murtaza,Saba Shamim
Cytoplasmic Polyadenylation Element Binding Protein 1 andAtherosclerosis: Prospective Target and New Insights
Journal: Current Vascular Pharmacology
Volume: 22 Issue: 2 Year: 2024 Page: 95-105
Author(s):
Targeting NUPR1 for Cancer Treatment: A Risky Endeavor
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 10 Year: 2020 Page: 768-778
Author(s): Salma M.A. Mansour,Sahar A. Ali,Shaira Nofal,Sameh H. Soror
Delta Np63 alpha â Responsive microRNA Modulate the Expression of Metabolic Enzymes
Journal: Current Pharmaceutical Biotechnology
Volume: 16 Issue: 9 Year: 2015 Page: 832-850
Author(s): Edward A. Ratovitski